Cynosure Group LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 61.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 897 shares of the healthcare conglomerate’s stock after selling 1,404 shares during the period. Cynosure Group LLC’s holdings in UnitedHealth Group were worth $525,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC lifted its holdings in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC lifted its holdings in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
UNH has been the topic of a number of recent research reports. TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. KeyCorp assumed coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Barclays lifted their price target on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $618.26.
UnitedHealth Group Stock Up 0.3 %
Shares of UNH opened at $608.38 on Thursday. The company has a market capitalization of $559.88 billion, a PE ratio of 39.63, a PEG ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock’s 50-day moving average price is $584.09 and its two-hundred day moving average price is $555.02. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $6.56 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- How to Invest in Blue Chip Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How Can Investors Benefit From After-Hours Trading
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.